CNTB · Connect Biopharma Holdings Ltd
$2.14
-0.06 (-2.73%)
At close · Jul 24
Market Cap
$134.74M
Shares
62.96M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.20
Open$2.15
Day$2.14–2.24
52W$1.23–3.82
Avg vol 30d550K
Short int2.1M · 3.3% float · 2.8d
Short vol57%
Last earningsJun 30, 2022
DataMar 2021–Jul 2026
Filing10-Q · May 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−8%
below
Price vs 50-day avg
−3%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
37%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+4%
trailing
6-month return
−14%
trailing
YTD return
−22%
this year
Relative strength
−20%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Distributing
5 of 40 funds reported for Jun 30 · net -36.4K sh shares · +1 new
Insider flow
Accumulating
Net +$371.6K over 90 days · 0% sells
Short interest
Rising
3.28% of float · ▲ +55.3% MoM · 2.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
40 holders — 13F breadth
Squeeze score
61
elevated · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
−257%
Y/Y
Free cash flow
$-51.6M
Balance sheet
$38.3M
net cash
Quant / Vol
risk profile
Volatility
97%
annualized · 1-yr
Max drawdown
−46%
past year
ATR
8.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−8%
Bearish
Price vs 50-day avg
−3%
Neutral
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
37%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Distributing
5 of 40 funds reported for Jun 30 · net -36.4K sh shares · +1 new
Insider flow
Accumulating
Net +$371.6K over 90 days · 0% sells
Short interest
Rising
3.28% of float · ▲ +55.3% MoM · 2.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
40 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $1
Now $2 · 37%
52-wk high $4
vs 200-day avg -8%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CNTB
this stock
Connect Biopharma Holdings Ltd
|
$134.74M | -22.0% | -99.8% | — | 3.3% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
40
- % held
- 20.6%
- Reported
- 5 of 40
- Top holder
- Ikarian Capital, LLC
Held
Float
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CNTB | -5.8% | +3.8% | -13.7% | -7.6% | -22.0% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -4.1% | +3.1% | -20.1% | -6.4% | -30.2% |